The study by Paiva and colleagues [1] provides valuable insights into intra-abdominal infections (IAI) in immunocompromised intensive care unit (ICU) patients, highlighting similarities and differences with immunocompetent individuals regarding disease presentation, microbial etiology, and outcomes. While the research is insightful, certain aspects of the study's methodology and the interpretation of its findings warrant further discussion.
